| |
| |
|
| Insider
Information: |
Bassler Bonnie L |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
49,456 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,687,426 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,456 |
|
|
| Total
Value |
$2,687,426 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -2.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-02-26 |
1,382 |
2019-01-02 |
0 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2024-03-28 |
47,762 |
2020-06-18 |
0 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
Director |
2021-01-22 |
312 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDTX |
Cidara Therapeutics, Inc. |
Director |
– • – |
2021-01-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
312 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
323 |
323 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
320 |
643 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-06-05 |
4 |
OE |
$391.92 |
$1,002,923 |
D/D |
2,559 |
3,202 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-06-05 |
4 |
AS |
$600.00 |
$1,535,400 |
D/D |
(2,559) |
643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-06-19 |
4 |
AS |
$630.01 |
$1,612,211 |
D/D |
(2,559) |
643 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2020-06-19 |
4 |
OE |
$391.92 |
$1,002,923 |
D/D |
2,559 |
3,202 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
891 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-07-01 |
4 |
AS |
$575.00 |
$1,470,850 |
D/D |
(2,558) |
891 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-07-01 |
4 |
OE |
$391.92 |
$1,002,531 |
D/D |
2,558 |
3,449 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-05 |
4 |
AS |
$600.00 |
$1,535,400 |
D/D |
(2,559) |
891 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-05 |
4 |
OE |
$391.92 |
$1,002,923 |
D/D |
2,559 |
3,450 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-16 |
4 |
OE |
$376.69 |
$459,185 |
D/D |
1,219 |
2,110 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-16 |
4 |
AS |
$630.00 |
$767,970 |
D/D |
(1,219) |
891 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
191 |
1,082 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-30 |
4 |
AS |
$700.00 |
$868,000 |
D/D |
(1,240) |
1,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-30 |
4 |
OE |
$380.95 |
$472,378 |
D/D |
1,240 |
2,322 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-04-07 |
4 |
AS |
$725.00 |
$899,000 |
D/D |
(1,240) |
1,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-04-07 |
4 |
OE |
$380.95 |
$472,378 |
D/D |
1,240 |
2,322 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-09-08 |
4 |
AS |
$686.99 |
$1,780,355 |
D/D |
(2,558) |
1,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-09-08 |
4 |
OE |
$391.92 |
$1,002,531 |
D/D |
2,558 |
2,361 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-09-09 |
4 |
AS |
$741.00 |
$451,269 |
D/D |
(609) |
1,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-09-09 |
4 |
OE |
$376.69 |
$229,404 |
D/D |
609 |
1,691 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-12-08 |
4 |
AS |
$779.00 |
$169,822 |
D/D |
(218) |
1,082 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-12-08 |
4 |
OE |
$380.95 |
$83,047 |
D/D |
218 |
1,300 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
